Cipla to sell animal health business in South Africa
Pharma firm Cipla on Sunday said it plans to sell its animal health business in South Africa and Sub-Saharan Africa for a consideration of about Rs 191 crore.
The company has entered into agreements through its wholly-owned subsidiary Inyanga Trading 386 Proprietary, with the group companies of Ascendis Health. Under the agreements, Cipla will divest its 100% stake in Cipla Agrimed Proprietary South Africa and Cipla Vet Proprietary, South Africa.
Ascendis Health is a health and care brands company operating in human, plant and animal health domains, while Cipla Agrimed operates in the farm animals segment, with sales mainly to agricultural cooperatives and bulk farm purchasing organisations.
Disclaimer: Please write your correct name and email address. Kindly do not post any personal, abusive, defamatory, infringing, obscene, indecent, discriminatory or unlawful or similar comments. Konkanworld.com will not be responsible for any defamatory message posted under this article. Please note that under 66A of the IT Act, sending offensive or menacing messages through electronic communication service and sending false messages to cheat, mislead or deceive people or to cause annoyance to them is punishable. It is obligatory on Konkanworld.com to provide the IP address and other details of senders of such comments, to the authority concerned upon request. Hence, sending offensive comments using Konkanworld.com will be purely at your own risk, and in no way will Konkanworld.com be held responsible. Similarly, Konkanworld.com reserves the right to edit / block / delete the messages without notice any content received from readers.